Projects

It takes two flints to make a fire

Projects

With a track record of successfully delivering complex projects, our expertise spans the full spectrum of biotech and pharma manufacturing. From concept to execution, we provide innovative solutions tailored to the evolving needs of the biotechnology, pharmaceutical, and advanced therapy industries.
Our experience includes, but is not limited to:

4.7
5/5
Rating Customer

Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

A+
5/5
Software Class

Lorem ipsum dolor sit amet, consectetur adipiscing elit. 

Generic Pharma
Small Molecules
Blood Plasma
large Molecules - Biologics
Vaccines & mRNA Therapeutics
Viral Victor - Cell & Gene Therapy

GMP Engineering

€500M

Project Value

Feasibility and Concept 30,000 m² Facility

$1.5B

OVER 10 Years Project Value

250 Acres Vaccine Manufacturing, Inspection & Fill-Finish Facility

€500M

Project Value

100,000 m² Bulk Vaccine Facility

€200M

Project Value

60,000 m² Bulk Vaccine Facility

€350M

Project Value

46,000 m² Bulk Vaccine Facility

$100M

Project Value

Recombinant Manufacturing Facility

$450M

Project Value

High Potent Modality Agnostic Large Scale Pilot Plant

number-6

$100M

Project Value

Recombinant Manufacturing Facility

GMP Engineering

$14M

Project Value

20,500 sq. ft. New GMP Facility for solid oral dosage manufacturing

$4M

Project Value

4000 sq. ft. New GMP Cell & Gene Therapy Manufacturing Space

$140M

Project Value

For upgrading process and automation systems (upstream, downstream and supporting utilities/ buffers/CIP)

$100M

Project Value

Providing entire end to end C&Q service scope for Greenfield OSD site

$50M

Project Value

PM and C&Q for mRNA vaccine manufacturing process and a singleuse bioprocess facility expansion

$670M

Project Value

PM/Owner Rep Plasma Facility expansion (Process, Automation, Utilities, Architecture)

$100M

Project Value

Capital project management and project controls for two train, and Tank Farm expansion projects

number-6

$100M

Project Value

Recombinant Manufacturing Facility

Fredlab

GMP Engineering

€100M

Project Value

25,000 square meter, Development of the vaccine facility, including the establishment of QC (Quality Control) areas

€60M

Project Value

16,000 square meter, New facility featuring two generic OSD (Oral Solid Dosage) lines, one liquid production line, and two injectable lines (LVP + SVP), along with all required utilities

$250M

Project Value

100,000 square meter, Pharmaceutical hub comprising four manufacturing buildings (OSD, OSD Cephalosporins, OSD Beta-Lactams, and Injectables – 1x LVP + 2x SVPs), along with a dedicated QC and R&D building and all necessary utilities

number-4

€200M

Project Value

60,000 m² Bulk Vaccine Facility

number-5

€350M

Project Value

46,000 m² Bulk Vaccine Facility

number-6

$100M

Project Value

Recombinant Manufacturing Facility

number-7

$450M

Project Value

High Potent Modality Agnostic Large Scale Pilot Plant

number-5

€350M

Project Value

46,000 m² Bulk Vaccine Facility

number-6

$100M

Project Value

Recombinant Manufacturing Facility

Clients